None listed
Conditions
Brief summary
Electromagnetic Millimetre Wave Therapy (EMT), originally developed in Russia, has shown promise in pain relief therapy in several randomised controlled trials conducted in the USA and Europe in the last 15 years. EMT was shown to be effective in reducing painful conditions, including joint pain, headache, postoperative pain, and neuropathic pain. Aims of this study In this study, we want to find out: 1. The effect of EMT on pain relief 2. The effect of EMT on pain related quality of life 3. The duration of pain relief by EMT 4. The tolerability of EMT The proposed study will be a preliminary investigation of the effectiveness of EMT in pain relief. Data will inform the proposal for a larger cohort study. Patients, presenting with chronic pain and attending the NIIM clinic, will be approached to participate. Pain levels and locations will be variable, in this pilot phase. Consenting patients will be treated with EMT therapy for 15 minutes. Subjective pain levels, and the impact on the quality of life will be assessed at baseline, shortly after EMT treatment, and at regular intervals for three days after the clinical session, using validated pain scales.
Interventions
Electromagnetic Millimetre Wave Therapy (EMT), originally developed in Russia, has shown promise in pain relief therapy in several randomised controlled trials conducted in the USA and Europe in the last 15 years. EMT was shown to be effective in reducing painful conditions, including joint pain, headache, postoperative pain, and neuropathic pain.
EMT involves a local exposure of the skin (2-3 cm2) to low power electromagnetic waves (<20mW/cm2) in the millimetre range (30-300GHz).
Phase 1: Conse
Electromagnetic Millimetre Wave Therapy (EMT), originally developed in Russia, has shown promise in pain relief therapy in several randomised controlled trials conducted in the USA and Europe in the last 15 years. EMT was shown to be effective in reducing painful conditions, including joint pain, headache, postoperative pain, and neuropathic pain. EMT involves a local exposure of the skin (2-3 cm2) to low power electromagnetic waves (<20mW/cm2) in the millimetre range (30-300GHz). Phase 1: Consenting patients will holds the device on Day 1 once for 15 minutes either to the localised area of pain or, in case of systemic pain, to the sternum. Phase 2: Treatment is to be repeated 4x a week on every 2nd day as per protocols in the literature. EMT may have three main effects: (i) sedative and analgesic; (ii) anti-inflammatory action and enhancement of tissue generation processes and (iii) immune stimulation.
Sponsors
National Institute of Integrative Medicine
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Healthy volunteers
No
Inclusion criteria
Adults 18-80 years, presenting with pain experienced for at least 1 month
Exclusion criteria
acute pain (< 1 month)
Outcome results
None listed